88
33
Growth Score
10 pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
326597
Leukogene Therapeutics is a cancer biotherapeutics company delivering innovative immunotherapies for patients living with cancer.
- Sandeep Gupta: CEOPast Role: Asana BioSciences, Founder, President & CEO
About the Company
Leukogene Therapeutics is Charleston, SC based oncology focused biotech company, a spin-out from the Medical University of South Carolina (MUSC). Their mission is to deliver innovative immunotherapies for hard-to-treat cancers with emphasis on immunologically “cold” tumors. Leukogene’s MHC class II targeted M2T™ immunotherapy directs and mobilizes
the immune system to trigger a robust, tumor antigen specific immune response and eliminate tumor cells. Their lead candidates in acute myeloid leukemia (AML) and pancreatic ductal adenocarcinoma (PDAC) have already demonstrated preclinical proof of concept.
